| six-month follow-up | Not tested |  |
---|---|---|---|
Characteristics | (n = 43) | (n = 136) | p valuea |
Age in years, median (IQR) | 52 (39–65) | 55 (42–68) | 0.39 |
Female, percentage (number/total) | 53 (23/43) | 49 (66/136) | 0.60 |
Black, percentage (number/total) | 16 (7/43) | 24 (33/136) | 0.40 |
Charlson Comorbidity Index, median (IQR) | 3 (2–5) | 3 (1–5) | 0.34 |
APACHE II score, median (IQR) | 25 (20–31) | 25 (18–31) | 0.63 |
ICU admission diagnosisb, percentage (number/total) | Â | Â | Â |
   Sepsis and/or acute respiratory distress syndrome | 42 (18/43) | 49 (66/136) | 0.49 |
   Pneumonia | 26 (11/43) | 15 (21/136) | 0.17 |
   Myocardial infarction/Congestive heart failure | 9 (4/43) | 9 (12/136) | 1.00 |
   Hepatic or renal failure | 12 (5/43) | 1 (1/136) | 0.003 |
   COPD | 2 (1/43) | 10 (14/136) | 0.12 |
   Gastrointestinal bleeding | 2 (1/43) | 10 (14/136) | 0.12 |
   Malignancy | 5 (2/43) | 2 (3/136) | 0.59 |
   Drug overdose | 5 (2/43) | 7 (9/136) | 1.00 |
   Other | 21 (9/43) | 34 (46/136) | 0.13 |
ICU length of stay in days, median (IQR) | 10 (5–13) | 7 (5–10) | 0.08 |
Days on mechanical ventilation, median (IQR) | 5 (3–12) | 6 (3–9) | 0.61 |
Duration of coma in days, median (IQR) | 1 (0–3) | 1 (0–2) | 0.16 |
Duration of delirium in days, median (IQR) | 2 (1–3) | 2 (1–3) | 0.39 |